Rare lephants
Screener

Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13D Jul 29, 2008 FORM SC 13D
3 Jul 17, 2008 MAIN DOCUMENT DESCRIPTION
3 Jul 17, 2008 MAIN DOCUMENT DESCRIPTION
8-K Jul 15, 2008 FORM 8-K
CORRESP Jul 11, 2008
8-K Jul 1, 2008 FORM 8-K
UPLOAD Jun 26, 2008
8-K Jun 3, 2008 FORM 8-K
4 May 14, 2008 PRIMARY DOCUMENT
8-K May 12, 2008 FORM 8-K
10-Q May 7, 2008 FORM 10-Q
8-K Apr 9, 2008 FORM 8-K
10-K Mar 17, 2008 FORM 10-K
4 Mar 12, 2008 MAIN DOCUMENT DESCRIPTION
4 Feb 26, 2008 PRIMARY DOCUMENT
4 Feb 13, 2008 FORM 4
4 Feb 13, 2008 FORM 4
4 Feb 13, 2008 FORM 4
4 Feb 13, 2008 FORM 4
8-K Feb 13, 2008 FORM 8-K
S-8 Feb 1, 2008 FORM S-8
8-K Jan 22, 2008 FORM 8-K
8-K Jan 17, 2008 FORM 8-K
DEF 14A Dec 31, 2007 DEFINITIVE PROXY STATEMENT
4 Dec 26, 2007 PRIMARY DOCUMENT
← Newer Page 32 of 38 · 935 filings Older →